ICM-2021 | Osaka, Japan

Highlights of the ICM-2021

• Designing 40+ Hot Sessions of Scientific Forums, Dialogs and Roundtables
• Shooting for 200+ Oral Presentations in Whole Medicinal Chemistry Fields
• Gathering 50+ Posters and Exhibitors in Cutting-edge Technologies and Novel Methods
• Bringing in 20+ Professional Media Supporters
• Experiencing a Cultural Atmosphere of Osaka

Renowned Speakers of Previous Events

*Dr. Dave Madge,* VP, Research Service Division, WuXi AppTec, Inc., China	*Dr. Jeff Reaga,* Scientific Director, Amgen, USA	*Dr. Robert Plumb,* Director of Metabolic Phenotyping and Stratified Medicine,Waters Corporation, USA
*Dr. Le Sun,* President & CEO, AbMax Biotechnology, China	*Dr. Kiyoshi Nokihara,* CEO & CSO, HiPep Laboratories, Japan	*Dr. Xian Bu,* Co-Founder and Managing Director, SYNthesis med chem, USA
*Dr. Laure Bouchez,* Director, Glenmark Therapeutics, USA	*Dr. Wei Zhang,* Associate Professor, University of Massachusetts Boston, USA	*Dr. Jiren Zhang,* Professor, Oncology Center, ZhuJiang Hospital of Southern Medical University, China
*Dr. Kevin Liu,* Head of Chemistry, Global Discovery Chemistry, Novartis Institute of Biomedical Research, China	*Dr. Hakim Mohamed,* President and CEO, Once Source Clinical & Management, USA	*Dr. Henrietta Ukwu,* Senior Vice President, Head of Global Regulatory Affairs,Otsuka,USA
*Dr. Maode Lai,* Academician of Nationale Akademie der Wissenschafte, President, China Pharmaceutical University, China	*Dr. Christopher Abell,* Fellow of the Royal Society, Pro-Vice-Chancellor for Research,The University of Cambridge,UK	*Dr. Richard Soll,* Senior Vice President and Head of International Discovery Service Unit,WuXi AppTec, USA
*Dr. Jan Hoflack,* Chief Scientific and Operational Officer, Oncodesign SA, France	*Dr. Howard J. Federoff,* Vice Chancellor of Health Affairs and Chief Executive Officer of Health System, University of California, Irvine, USA	*Dr. Litao Zhang,* Vice President, Leads Discovery and Optimization, Bristol-Myers Squibb, USA
*Dr. Tom Mander,* Chief Operating Officer, Domainex Ltd., UK	*Dr. Bruce Given,* COO, Arrowhead Research Corporation, USA	*Dr. Chris H. Senanayake,* Vice President, Boehringer Ingelheim Pharmaceuticals, Inc., USA
*Dr. Tina Tao,* Head of APAC E2E Biodevelopment Center, Merck Group, China	*Dr. John Lambert,* Corporate Vice President and Chief Medical Officer, PAREXEL International Shanghai, China	*Dr. Gerald J. Yakatan,* Chairman & CEO, IriSys, LLC,.USA
*Dr. Akiyoshi Suganuma,* Group Officer and President of BA-CFU, Medicine Development Center, Eisai Co., Ltd., Japan	*Dr. David C. Bunton,* CEO, REPROCELL Europe Ltd., UK	*Dr. Steffen Denzinger,* Director, Strategy and Business Development Process Solutions, Merck Millipore, Germany
*Dr. Eric Westhof, Academician,* Vice President for Research and Doctoral Studies of the University of Strasbourg, France	*Dr. Wei Li,* Professor and Director of UTCoP Drug Discovery Center, University of Tennessee Health Science Center, USA	*Dr. A. Vieira,* Director, Metabolic Research Lab, Simon Fraser University, Canada
*Dr. Dieter Lubda,* Head Actives Formulation RD Operations, Life Science \| Process Solutions \| Actives Formulation, Merck, Germany	*Dr. Jeffery Liu,* Director, GSK, USA	*Dr. Guo-Ping Zhou,* Adjunct Professor, Harvard Medical School, USA

Program at a Glance

Program Layout
Stage 1: Keynote Forum -Big Thinkers for Next Generation Medichem	Stage 2: New Era of Medichem Science & Tech Disruption -Strategic Innovators Enable Early Drug Discovery
Stage 3: Pioneerscape of Target Druggability -Leadership in Discovering Validated Targets	Stage 4: New Shapers of Drug Chemical Modalities -Booming Achievement in Discovery New Chemical Diversities
Stage 5: Drug Design Artists -Intelligent Creation of Potential Hit to Leads	Stage 6: Masters of Discovery Synthetic Tool Box -Robust Chemistry toward Desired Candidates
Stage 7: Accelerators of Bio/Physical Testing -Shortening the Preclinical Process	Stage 8: Integrative Discovery Chemistry Servers -Future of CRO,CSO,CMO, CXO
Stage 9: Smart Inventors Hackling Unmet Diseases -Next $Billion Solutions to Unsolved Man’s Disorders	Stage 10: Futurists of Discovery Chemistry -Young Chemists’ Short Talks
Stage 11: Women Experts in Medichem -Making Medichem World Family Diversified	Stage 12: Mentors of New Concepts in Medichem -Knowledge Drives To Success

Sponsors & Exhibitors

Sponsors	Exhibitors
● Sponsorship provides a great means of broadening your competitive edge by improving your company's image, prestige and credibility by supporting events that your target market finds attractive.	● This conference provides your company with an unparalleled marketing opportunity to get before industry decision-makers. Exhibiting at the right exhibition can be one of the most efficient, effective and successful marketing activities available to you.
More	More